Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
This report elaborates on the current development of the Biosimilar of Remicade industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Novartis (Sandoz)
Hospira
LG Life Sciences
Celltrion
Biogen idec Inc
Genentech (Roche Group
ynthon Pharmaceuticals
Merck Serono (Merck Group)
By Type:
100mg/10ml
500mg/50ml
By Application:
Blood Disorders
Oncology Diseases
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Biosimilar of Remicade Market Overview 2018-2029
-
1.1 China Biosimilar of Remicade Industry Development Overview
-
1.2 China Biosimilar of Remicade Industry Development History
-
1.3 China Biosimilar of Remicade Industry Market Size (2018-2029)
-
1.4 China Biosimilar of Remicade Market Analysis by Type from Production Side
-
1.4.1 China Biosimilar of Remicade Production Volume, Production Value and Growth Rate of 100mg/10ml (2018-2029)
-
1.4.2 China Biosimilar of Remicade Production Volume, Production Value and Growth Rate of 500mg/50ml (2018-2029)
-
1.5 China Biosimilar of Remicade Market Analysis by Application from Consumption End
-
1.5.1 China Biosimilar of Remicade Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)
-
1.5.2 China Biosimilar of Remicade Sales Volume, Sales Value and Growth Rate of Oncology Diseases (2018-2029)
-
1.6 China Biosimilar of Remicade Market Analysis by Region
-
1.6.1 North China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
Chapter 2 China Biosimilar of Remicade Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Biosimilar of Remicade Market Status and Competition at home and abroad in 2023
-
2.2.2 China Biosimilar of Remicade Market Status and Competition Analysis in 2023
-
2.2.3 China Biosimilar of Remicade Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Biosimilar of Remicade Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Biosimilar of Remicade Industry Development
Chapter 3 Biosimilar of RemicadeIndustry Chain Analysis
-
3.1 Biosimilar of Remicade Industry Chain
-
3.2 Biosimilar of Remicade Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Biosimilar of Remicade Market
-
3.3 Biosimilar of Remicade Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Biosimilar of Remicade Market
Chapter 4 China Biosimilar of Remicade Market, by Type
-
4.1 China Biosimilar of Remicade Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Biosimilar of Remicade Total Production Volume and Growth Rate from Production Side
-
4.5 China Biosimilar of Remicade Production Volume and Growth Rate, by Type
-
4.5.1 China Biosimilar of Remicade Production Volume and Growth Rate of 100mg/10ml
-
4.5.2 China Biosimilar of Remicade Production Volume and Growth Rate of 500mg/50ml
Chapter 5 China Biosimilar of Remicade Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Biosimilar of Remicade Total Market Size and Growth Rate from Consumption End
-
5.5 China Biosimilar of Remicade Market Size and Growth Rate, by Application
-
5.5.1 China Biosimilar of Remicade Market Size and Growth Rate of Blood Disorders
-
5.5.2 China Biosimilar of Remicade Market Size and Growth Rate of Oncology Diseases
Chapter 6 China Biosimilar of Remicade Market, by Region
-
6.1 China Biosimilar of Remicade Production Volume and Production Value, by Region
-
6.2 China Biosimilar of Remicade Sales Volume and Sales Value, by Region
Chapter 7 North China Biosimilar of Remicade Market Analysis
-
7.1 North China Biosimilar of Remicade Market, by Type
-
7.2 North China Biosimilar of Remicade Market, by Application
Chapter 8 Central China Biosimilar of Remicade Market Analysis
-
8.1 Central China Biosimilar of Remicade Market, by Type
-
8.2 Central China Biosimilar of Remicade Market, by Application
Chapter 9 South China Biosimilar of Remicade Market Analysis
-
9.1 South China Biosimilar of Remicade Market, by Type
-
9.2 South China Biosimilar of Remicade Market, by Application
Chapter 10 East China Biosimilar of Remicade Market Analysis
-
10.1 East China Biosimilar of Remicade Market, by Type
-
10.2 East China Biosimilar of Remicade Market, by Application
Chapter 11 Northeast China Biosimilar of Remicade Market Analysis
-
11.1 Northeast China Biosimilar of Remicade Market, by Type
-
11.2 Northeast China Biosimilar of Remicade Market, by Application
Chapter 12 Southwest China Biosimilar of Remicade Market Analysis
-
12.1 Southwest China Biosimilar of Remicade Market, by Type
-
12.2 Southwest China Biosimilar of Remicade Market, by Application
Chapter 13 Northwest China Biosimilar of Remicade Market Analysis
-
13.1 Northwest China Biosimilar of Remicade Market, by Type
-
13.2 Northwest China Biosimilar of Remicade Market, by Application
Chapter 14 Company Profiles
-
14.1 Novartis (Sandoz)
-
14.1.1 Novartis (Sandoz) Company Profile
-
14.1.2 Novartis (Sandoz) Biosimilar of Remicade Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Hospira
-
14.2.1 Hospira Company Profile
-
14.2.2 Hospira Biosimilar of Remicade Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 LG Life Sciences
-
14.3.1 LG Life Sciences Company Profile
-
14.3.2 LG Life Sciences Biosimilar of Remicade Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Celltrion
-
14.4.1 Celltrion Company Profile
-
14.4.2 Celltrion Biosimilar of Remicade Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Biogen idec Inc
-
14.5.1 Biogen idec Inc Company Profile
-
14.5.2 Biogen idec Inc Biosimilar of Remicade Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Genentech (Roche Group
-
14.6.1 Genentech (Roche Group Company Profile
-
14.6.2 Genentech (Roche Group Biosimilar of Remicade Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 ynthon Pharmaceuticals
-
14.7.1 ynthon Pharmaceuticals Company Profile
-
14.7.2 ynthon Pharmaceuticals Biosimilar of Remicade Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Merck Serono (Merck Group)
-
14.8.1 Merck Serono (Merck Group) Company Profile
-
14.8.2 Merck Serono (Merck Group) Biosimilar of Remicade Market Performance
-
14.8.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Biosimilar of Remicade Industry Research Conclusions
-
15.2 Biosimilar of Remicade Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Biosimilar of Remicade Industry Market Size (2018-2029)
-
Figure China Biosimilar of Remicade Production Volume, Production Value and Growth Rate of 100mg/10ml (2018-2029)
-
Figure China Biosimilar of Remicade Production Volume, Production Value and Growth Rate of 500mg/50ml (2018-2029)
-
Figure China Biosimilar of Remicade Sales Volume, Sales Value and Growth Rate of Blood Disorders (2018-2029)
-
Figure China Biosimilar of Remicade Sales Volume, Sales Value and Growth Rate of Oncology Diseases (2018-2029)
-
Figure North China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure Central China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure South China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure East China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Biosimilar of Remicade Market Size and Growth Rate from 2018-2029
-
Figure Biosimilar of Remicade Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Biosimilar of Remicade Market Share by Type in 2018
-
Figure China Biosimilar of Remicade Market Share by Type in 2023
-
Figure China Biosimilar of Remicade Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Biosimilar of Remicade Production Volume and Growth Rate of 100mg/10ml (2018-2023)
-
Figure China Biosimilar of Remicade Production Volume and Growth Rate of 500mg/50ml (2018-2023)
-
Figure China Biosimilar of Remicade Market Share by Application in 2018
-
Figure China Biosimilar of Remicade Market Share by Application in 2023
-
Figure China Biosimilar of Remicade Total Market Size and Growth Rate from Consumption End
-
Figure China Biosimilar of Remicade Market Size and Growth Rate of Blood Disorders (2018-2023)
-
Figure China Biosimilar of Remicade Market Size and Growth Rate of Oncology Diseases (2018-2023)
-
Table China Biosimilar of Remicade Production Volume by Region (2018-2023)
-
Table China Biosimilar of Remicade Production Volume Share by Region (2018-2023)
-
Figure China Biosimilar of Remicade Production Volume Share by Region (2018-2023)
-
Table China Biosimilar of Remicade Production Value by Region (2018-2023)
-
Table China Biosimilar of Remicade Production Value Share by Region (2018-2023)
-
Figure China Biosimilar of Remicade Production Value Share by Region (2018-2023)
-
Table China Biosimilar of Remicade Sales Volume by Region (2018-2023)
-
Table China Biosimilar of Remicade Sales Volume Share by Region (2018-2023)
-
Figure China Biosimilar of Remicade Sales Volume Share by Region (2018-2023)
-
Table China Biosimilar of Remicade Sales Value by Region (2018-2023)
-
Table China Biosimilar of Remicade Sales Value Share by Region (2018-2023)
-
Figure China Biosimilar of Remicade Sales Value Share by Region (2018-2023)
-
Table North China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table North China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure North China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table North China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table North China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure North China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table Central China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table Central China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure Central China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table Central China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table Central China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure Central China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table South China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table South China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure South China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table South China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table South China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure South China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table East China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table East China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure East China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table East China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table East China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure East China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table Northeast China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table Northeast China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure Northeast China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table Northeast China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table Northeast China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table Southwest China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table Southwest China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure Southwest China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table Southwest China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table Southwest China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table Northwest China Biosimilar of Remicade Production Volume by Type (2018-2023)
-
Table Northwest China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Figure Northwest China Biosimilar of Remicade Production Volume Share by Type (2018-2023)
-
Table Northwest China Biosimilar of Remicade Sales Volume by Application (2018-2023)
-
Table Northwest China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Biosimilar of Remicade Sales Volume Share by Application (2018-2023)
-
Table Novartis (Sandoz) Company Profile
-
Table Novartis (Sandoz) Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table Hospira Company Profile
-
Table Hospira Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table LG Life Sciences Company Profile
-
Table LG Life Sciences Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table Celltrion Company Profile
-
Table Celltrion Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table Biogen idec Inc Company Profile
-
Table Biogen idec Inc Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table Genentech (Roche Group Company Profile
-
Table Genentech (Roche Group Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table ynthon Pharmaceuticals Company Profile
-
Table ynthon Pharmaceuticals Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
Table Merck Serono (Merck Group) Company Profile
-
Table Merck Serono (Merck Group) Biosimilar of Remicade Revenue, Price and Gross (2018-2023)
-
